|
8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[c]chromen-6-one |
|---|---|
| Trade Name | |
| Orphan Indication | Glioblastoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-01-21 00:00:00 |
| Sponsor | Diffusion Pharmaceuticals, Inc.;2020 Avon Court, Suite 4;Charlottesville, Virginia, 22902 |
